Krazati 200 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DR26FL8RL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,310
Award facts
- Contract value 100% obligated
- $13,309.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,309.58 to AmerisourceBergen Drug Corp for the supply of Krazati 200 mg tablets (180 count) on November 13, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement supporting military healthcare operations globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's portfolio under the DLA framework encompasses a comprehensive range of pharmaceuticals including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Krazati—a targeted cancer therapy—reflects AmerisourceBergen's role as a key supplier of specialized pharmaceutical products supporting military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FL8RL?
SPE2DR26FL8RL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FL8RL worth?
The government has obligated $13,310 on SPE2DR26FL8RL.
Is contract SPE2DR26FL8RL an order under another contract?
Yes. SPE2DR26FL8RL is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL8RL competed?
The extent of competition for SPE2DR26FL8RL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award